<DOC>
	<DOCNO>NCT00466661</DOCNO>
	<brief_summary>To conduct double-blind , randomize , placebo-controlled outpatient clinical trial acamprosate individual alcohol dependence bipolar disorder also receive mood stabilize medication . The study assess safety efficacy acamprosate alcohol-dependent bipolar patient measure effect alcohol use mood symptom relative placebo . The primary hypothesis test whether individual comorbid bipolar disorder alcohol dependence receive acamprosate plus mood stabilizer great improvement alcohol-related outcome receive mood stabilizer alone . A secondary hypothesis explore alcohol-dependent bipolar individual treat acamprosate great mood stability compare treat mood stabilizer alone .</brief_summary>
	<brief_title>Acamprosate v . Placebo Bipolar Alcoholics</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Acamprosate</mesh_term>
	<criteria>1 . Adults age 1865 2 . Meet DSMIV criterion current ( past 90 day ) alcohol dependence 3 . Meet DSMIV criterion bipolar I bipolar II disorder 4 . Currently mood stabilize medication regimen , include use lithium , valproic acid , lamotrigine , carbamazepine , and/or antipsychotic agent FDA approve treat bipolar disorder without dosage adjustment past 30 day 5 . Must able remain free alcohol least 3 day prior medication initiation 6 . Subjects must able adequately provide informed consent function intellectual level sufficient allow accurate completion assessment instrument 7 . Subjects must consent random assignment willing commit medication treatment followup assessment 1 . Individuals primary psychiatric disorder bipolar disorder 2 . Individuals uncontrolled neurologic condition could confound result study 3 . Individuals uncontrolled medical condition may adversely affect conduct trial jeopardize subject 's safety 4 . Participants creatinine clearance less equal half normal value indicate chem . 7 result conduct screening visit . 5 . Concomitant use psychotropic medication allow per protocol 6 . Women childbearing potential pregnant , lactate refuse use adequate form birth control 7 . Current suicidal homicidal risk 8 . Baseline score &gt; 35 Montgomery Asberg Depression Rating Scale and/or &gt; 25 Young Mania Rating Scale</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Acamprosate</keyword>
	<keyword>Alcoholism</keyword>
	<keyword>Bipolar disorder</keyword>
	<keyword>Comorbidity</keyword>
	<keyword>Craving</keyword>
	<keyword>Depression</keyword>
	<keyword>GABA</keyword>
	<keyword>Glutamate</keyword>
	<keyword>Mania</keyword>
	<keyword>Pharmacotherapy</keyword>
	<keyword>Withdrawal</keyword>
</DOC>